hyoscyamine sulfate 0.125 MG Sublingual Tablet [Oscimin]

RxCUI
1652363
RxNorm name
hyoscyamine sulfate 0.125 MG Sublingual Tablet [Oscimin]
Display name
OSCIMIN (Sublingual)
Full name
hyoscyamine sulfate 0.125 MG Sublingual Tablet [Oscimin]
Term type
SBD
Status
Active
Strength
0.125 mg
Dose form
Tab
Route
Sublingual
Updated
2026-10-17 23:58:22

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072015
Active start
072015
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
hyoscyamine sulfate0.125 MG / 1 EACHhyoscyaminehyoscyamine sulfate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Sublingual Tablet317007

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
hyoscyamine153970

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STROscimin 0.125 MG Sublingual Tablet1NAMES
RxNorm Namehyoscyamine sulfate 0.125 MG Sublingual Tablet [Oscimin]1NAMES
RxNorm SynonymOscimin 0.125 MG Sublingual Tablet1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID2d5fa637-0696-40fe-9bc1-fcb6f07a50f61CODES
RxCUI16523631CODES
MMSL_CODEBD52651CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
68047-253-0168047-253OSCIMIN Hyoscyamine SulfateLarken Laboratories, Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
68047025301rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OSCIMINHYOSCYAMINE SULFATELarken Laboratories, Inc.2d5fa637-0696-40fe-9bc1-fcb6f07a50f62025-10-16Warnings, Adverse reactionsExact identifier
ndc (package): 68047-253-01
ndc (product): 68047-253
ndc11 (package): 68047025301
rxcui: 1652363

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2d5fa637-0696-40fe-9bc1-fcb6f07a50f6OSCIMIN 0.125 MG Sublingual Tablet [PSN] · hyoscyamine sulfate 0.125 MG Sublingual Tablet [Oscimin] [SBD] · Oscimin 0.125 MG Sublingual Tablet [SY]312OSCIMIN Sublingual Tablets20251016

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
2d5fa637-0696-40fe-9bc1-fcb6f07a50f6OSCIMIN Sublingual TabletsLarken Laboratories, Inc.20251016
2d5fa637-0696-40fe-9bc1-fcb6f07a50f6OSCIMIN Sublingual TabletsLarken Laboratories, Inc.20241011
8aa56575-1685-42d5-98c3-7e7857ee8d0aNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4hyoscyamine
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine sulfate
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine sulfate
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine sulfate
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine sulfate
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine sulfate
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine sulfate
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine sulfate
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine sulfate
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine sulfate
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine sulfate
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine sulfate
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine sulfate
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine sulfate
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine sulfate
MEDRTD014202TremorDISEASEmay_treathyoscyamine
MEDRTD014202TremorDISEASEmay_treathyoscyamine sulfate
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine sulfate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine sulfate
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine sulfate
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.125 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable SynonymOSCIMIN 0.125 MG Sublingual Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon